Gang Li

Mechanism of action of gypenosides on type 2 diabetes and non-alcoholic fatty liver disease in rats.

G. Zhan, Fang Li, H. Tan, 2015, World journal of gastroenterology.

Relationship between nonalcoholic fatty liver disease and coronary plaque stability and risk factors for composite cardiovascular adverse events

Jian-Yong Ma, Gang Li, Junfang Xuan, 2022, World Chinese Journal of Digestology.

MicroRNA‐26a–interleukin (IL)‐6–IL‐17 axis regulates the development of non‐alcoholic fatty liver disease in a murine model

G. Zhan, G. Li, R. Li, 2016, Clinical and experimental immunology.